Speaker
Patient Engagement Lead Oncology, Bayer
Zahra Trippe, Patient Engagement Lead Oncology at Bayer, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Integrating Radiopharmaceuticals into Standard of Care: Navigating Governance, Funding, Capacity, and Real-World Constraints”.
1–3 Dec 2026London, United Kingdom
Vice President CMC & Project Lead, OncoOne
Chief Executive Officer, OranoMed
Senior Expert - Strategic Therapeutic Innovation, Novartis
Director of Research, Brookline Capital Markets
Chief Technology Officer, Nuclide Therapeutics
Chief Technology Officer, Norroy North America Inc.
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Zahra Trippe, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].